VesiBeta ER 25mg (Mirabegron)

VesiBeta ER 25 mg (Mirabegron) – Comprehensive Product Information

Brand Name: VesiBeta ER
Generic Name: Mirabegron Extended Release (ER)
Strength: 25 mg
Form: Extended Release Tablet
Therapeutic Class: Beta-3 Adrenergic Agonist
Route of Administration: Oral
Prescription Required: Yes

What is VesiBeta ER 25 mg?

VesiBeta ER 25 mg is an extended-release oral medicine that contains Mirabegron, which is a specific beta-3 adrenergic receptor antagonist. It’s employed to control symptoms associated with the overactive bladder (OAB), such as urgency to urinate, frequency, and incontinence due to urge. Extended-release formulations allow for the use of daily dosing and provide effective symptom treatment with improved compliance of the patient.

Mirabegron is a different treatment from the conventional antimuscarinic medications used to treat active bladders, and offers alternatives that may have fewer adverse effects associated with constipation and dry mouth.

Indications (Uses)

VesiBeta ER 25 mg is prescribed for the treatment of:

• Overactive bladder syndrome (OAB) with symptoms of urgency in the urinary tract, an increase in frequency, and a need to urinate.
• The management of urinary incontinence and urgency in adults

It’s especially beneficial to those who are unable to tolerate or who do not take well to anticholinergic medications.

Mechanism of Action

Mirabegron works by selectively stimulating beta-3 adrenergic receptors that are located in the muscle that detrusors the bladder. In the case of activation, these receptors cause:

• Relaxation of the smooth muscle throughout the filling of the bladder phase
• Increase in bladder capacity, without increasing pressure inside the bladder

The result is a decrease in urge and frequency of urine as well as improved bladder control.

Dosage and Administration

• Recommended Dose: A tablet of 25 mg once every day, chewed orally and without or with food.
• Dose Adjustment: Based on the clinical response and tolerance, dosages can be increased to up to 50 mg daily, after about 4-8 weeks.
• Special Populations:
  • For patients suffering from moderate renal impairment or liver impairment, dose adjustments are not usually required; however, caution should be taken.
  • The use of this method in cases of severe liver or renal impairment must be managed by a medical professional.
• Administration Tips:
  • Take the tablet in its entirety; do not chew or crush it.
  • Do this at the same times throughout the day to keep the same levels of drug.
• Missed Dose: If a dose has been missed, take it as fast as you can on the same day. Avoid double doses on the following day.

Benefits of VesiBeta ER 25 mg

• Increases bladder capacity and decreases the urgency and frequency that are associated with an overactive bladder.
• Once-daily dosing enhances patient compliance
• An alternative to the antimuscarinic drugs, with a completely different method of effect
• A lesser number of anticholinergic side effects, like constipation, dry mouth, and blurred vision
• Very well-tolerated by elderly patients with a high incidence of OAB
• It is possible to use it as a complement to antimuscarinic medication when monotherapy is ineffective.

Side Effects

As with all medicines, VesiBeta ER 25 mg may cause adverse reactions, although many patients take it with ease.

Common Side Effects:

• Increased blood pressure (hypertension)
• Nasopharyngitis (common cold symptoms)
• Headache
• Dizziness
• Urinary tract infection

Less Common Side Effects:

• Tachycardia (fast heart rate)
• Gastrointestinal discomfort (nausea, diarrhea)
• Fatigue
• Blurred vision

Serious Side Effects (Rare):

• Severe allergic reactions such as rash, itching, swelling, or difficulty breathing
• A significant increase in blood pressure needs medical intervention

If you are experiencing any extreme or unusual signs, get medical attention immediately.

Warnings and Precautions

• Hypertension: Keep track of blood pressure throughout treatments, particularly for patients who already have hypertension.
• Urinary Retention: Take care when using this method when you are dealing with patients susceptible to urinary retention, for example, those who have obstruction of the bladder outlet.
• Cardiovascular Disease: Be cautious when using Mirabegron in patients suffering from severe heart problems; Mirabegron could increase heart rate as well as blood pressure.
• Pregnancy and Lactation: The safety of breastfeeding and pregnancy isn’t fully established. Make sure that the advantages outweigh the risks.
• Drug Interactions: Mirabegron can interact with other drugs that are processed through the CYP2D6 enzyme, like digoxin and beta blockers, potentially increasing the levels of their plasma. Be sure to inform your doctor of the medications you take.
• Kidney and Liver Impairment: Take care when treating patients who have a hepatic or renal impairment that is severe.

Contraindications

• Hypersensitivity is known to Mirabegron, or any of the components in VesiBeta ER
• Hypertension that is severe and uncontrolled
• Patients suffering from chronic renal or hepatic impairment (consult your physician)
• Be cautious or stay away from those suffering from bladder or urinary obstruction.

How to Store VesiBeta ER 25 mg

• Maintain at room temperatures between 20°C and 25°C (68°F to 77°F).
• Beware of extreme heat, moisture, or intense sunlight.
• Make sure that the area is safe for children.
• Don’t use past the expiration date listed on the package.

Patient Counseling Information

• Use VesiBeta ER at the same time each day in order to keep constant blood levels.
• Don’t crush, chew, or break the tablet.
• Keep track of your blood pressure throughout the treatment.
• Inform your healthcare provider of any indications of reactions to an allergic substance or any significant change in your heart rate or the pressure of your blood to your doctor immediately.
• Tell your physician if you are planning to have a baby or are breastfeeding.
• Do not abruptly stop taking the medicine without consulting your physician.

Frequently Asked Questions (FAQs)

Q1: How long does it take for VesiBeta ER to work?

A1: The improvement in symptoms can be observed after 4 to 8 weeks of treatment.

Q2: Can I take VesiBeta ER with other bladder medications?

A2: Yes, It can be combined with antimuscarinic medications if recommended by your physician.

Q3: What should I do if I miss a dose?

A3: You should take the missed dose immediately the next day. Don’t take any additional tablets in the days following.

Q4: Are there dietary restrictions while taking VesiBeta ER?

A4: It is not a requirement to follow a specific diet. Needed, but the right diet can help improve the overall health of your bladder.

Q5: Can VesiBeta ER cause high blood pressure?

A5: Yes, It is possible that it will cause a rise in blood pressure. It is suggested to monitor your blood pressure regularly.

Conclusion

VesiBeta ER 25 mg (Mirabegron) offers an easy and effective treatment for those suffering from hyperactive bladder syndrome. Its distinctive beta-3 adrenergic activation mechanism relaxes bladder muscles, which reduces symptoms such as anxiety, frequency, and incontinence, without many of the typical negative side effects associated with anticholinergic medications.

Dosing once daily and having generally a positive safety profile, VesiBeta ER helps improve health and quality of life for those suffering from urinary issues that cause discomfort. Like all medications, one should use it under the direction of a doctor who will be monitoring your responses as well as any possible side effects.